2015 – 2017
- NARCAN® Nasal Spray approved by the FDA
- Changed name from Lightlake Therapeutics to Opiant Pharmaceuticals
- Licensed heroin vaccine from Walter Reed for Opioid Use Disorder (OUD)
- Initiated OPNT001 Phase 2 study of nasal naloxone in Bulimia Nervosa
- Uplisted to NASDAQ as $OPNT